Peter Boström

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database (2021)

Acta Radiologica Open

Jambor Ivan, Martini Albero, Falagario Ugo G, Ettala Otto, Taimen Pekka, Knaapila Juha, Syvänen Kari T, Steiner Aida, Verho Janne, Perez Ileana M, Merisaari Harri, Vainio Paula, Lamminen Tarja, Saunavaara Jani, Carrieri Giuseppe, Boström Peter J, Aronen Hannu J

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma (2021)

Scientific Reports

Mattila Kalle E., Laajala Teemu D., Tornberg Sara V., Kilpeläinen Tuomas P., Vainio Paula, Ettala Otto, Boström Peter J., Nisen Harry, Elo Laura L., Jaakkola Panu M.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies (2021)

European Urology Focus

Juha Knaapila, Ivan Jambor, Otto Ettala, Pekka Taimen, Janne Verho, Ileana Montoya Perez, Aida Kiviniemi, Tapio Pahikkala, Harri Merisaari, Tarja Lamminen, Jani Saunavaara, Hannu J.Aronen, Kari T.Syvänen, Peter J.Boström

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival (2021)

World Journal of Urology

Claps Francesco, van de Kamp Maaike W, Mayr Roman, Boström Peter J, Boormans Joost L, Eckstein Markus, Mertens Laura S, Boevé Egbert R, Neuzillet Yann, Burger Maximilian, Pouessel Damien, Trombetta Carlo, Wullich Bernd, van der Kwast Theo H, Hartmann Arndt, Allory Yves, Lotan Yair, Shariat Shahrokh F, Zuiverloon Tahlita CM, Mir M Carmen, van Rhijn Bas WG

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)

International Journal of Radiation Oncology - Biology - Physics

Dai Z, Jambor I, Taimen P, Pantelic M, Elshaikh MA, Dabaja A, Rogers C, Ettala O, Bostrom P, Aronen H, Merisaari H, Wen N

(O2 Muu julkaisu )

Which data are available in central registries on bladder cancer patients in the five Nordic countries (2021)

Scandinavian Journal of Urology

Körner Stefanie Korsgaard, Dreyer Thomas, Haug Erik Skaaheim, Jerlström Tomas, Boström Peter J, Gudjonsson Sigurdur, Jensen Jørgen Bjerggaard

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps (2021)

European Radiology

Hiremath Amogh, Shiradkar Rakesh, Merisaari Harri, Prasanna Prateek, Ettala Otto, Taimen Pekka, Aronen Hannu J, Boström Peter J, Jambor Ivan, Madabhushi Anant

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer (2021)

European Journal of Nuclear Medicine and Molecular Imaging

Malaspina Simona, Anttinen Mikael, Taimen Pekka, Löyttyniemi Eliisa, Kemppainen Jukka, Seppänen Marko, Boström Peter, Ettala Otto

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)

European Urology Oncology

Gregory J Nason, Michael A S Jewett, Peter J Boström, Hanan Goldberg, Aaron R Hansen, Philippe L Bedard, Jeremy Sturgeon, Padraig Warde, Peter Chung, Lynn Anson-Cartwright, Joan Sweet, Eshetu G Atenafu, Martin O'Malley, Robert J Hamilton

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Reply to Xuefeng Liu's Letter to the Editor, re: Kimmo Kettunen, Peter J. Bostrom, Tarja Lamminen, et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430-4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? (2020)

European Urology

Kimmo Kettunen, Peter Boström, Pekka Taimen

(Kirjoitus tai data-artikkeli tieteellisessä aikakauslehdessä (B1))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

How to read biparametric MRI in men with a clinical suspicious of prostate cancer: Pictorial review for beginners with public access to imaging, clinical and histopathological database (2021)

A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma (2021)

Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies (2021)

Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival (2021)

Accurate Prostate Cancer Detection and Segmentation Using Non-Local Mask R-CNN With Histopathological Ground Truth (2021)

Which data are available in central registries on bladder cancer patients in the five Nordic countries (2021)

Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps (2021)

Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer (2021)

Long-term Surveillance of Patients with Complete Response Following Chemotherapy for Metastatic Nonseminomatous Germ Cell Tumor (2020)